vs
NOVAVAX INC（NVAX）与Rapid7, Inc.（RPD）财务数据对比。点击上方公司名可切换其他公司
Rapid7, Inc.的季度营收约是NOVAVAX INC的1.5倍（$217.4M vs $147.3M），NOVAVAX INC净利率更高（11.9% vs 1.4%，领先10.5%），NOVAVAX INC同比增速更快（66.8% vs 0.5%），Rapid7, Inc.自由现金流更多（$36.4M vs $-41.6M），过去两年NOVAVAX INC的营收复合增速更高（25.3% vs 3.0%）
诺瓦瓦克斯是一家总部位于美国马里兰州盖瑟斯堡的生物科技企业，专注于传染病疫苗研发。其开发的新冠疫苗现由赛诺菲负责商业化，同时还在布局流感、呼吸道合胞病毒（RSV）、禽流感、带状疱疹、艰难梭菌感染、疟疾等多个领域的疫苗管线。
Rapid7是全球领先的网络安全企业，提供漏洞管理、威胁检测与响应、云安全、安全分析等全系列安全解决方案，服务全球科技、医疗、金融、制造等行业的各类规模企业及公共部门客户，助力客户高效识别、应对和缓解网络安全风险。
NVAX vs RPD — 直观对比
营收规模更大
RPD
是对方的1.5倍
$147.3M
营收增速更快
NVAX
高出66.3%
0.5%
净利率更高
NVAX
高出10.5%
1.4%
自由现金流更多
RPD
多$78.0M
$-41.6M
两年增速更快
NVAX
近两年复合增速
3.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $147.3M | $217.4M |
| 净利润 | $17.5M | $3.1M |
| 毛利率 | 85.0% | 68.9% |
| 营业利润率 | 9.7% | 1.0% |
| 净利率 | 11.9% | 1.4% |
| 营收同比 | 66.8% | 0.5% |
| 净利润同比 | 121.6% | 44.1% |
| 每股收益（稀释后） | $0.28 | $0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NVAXRPD
| Q4 25 | $147.3M | $217.4M | ||
| Q3 25 | $70.4M | $218.0M | ||
| Q2 25 | $239.2M | $214.2M | ||
| Q1 25 | $666.5M | $210.3M | ||
| Q4 24 | $88.3M | $216.3M | ||
| Q3 24 | $84.5M | $214.7M | ||
| Q2 24 | $415.5M | $208.0M | ||
| Q1 24 | $93.9M | $205.1M |
净利润NVAXRPD
| Q4 25 | $17.5M | $3.1M | ||
| Q3 25 | $-202.4M | $9.8M | ||
| Q2 25 | $106.5M | $8.3M | ||
| Q1 25 | $518.6M | $2.1M | ||
| Q4 24 | — | $2.2M | ||
| Q3 24 | $-121.3M | $15.4M | ||
| Q2 24 | $162.4M | $6.5M | ||
| Q1 24 | $-147.6M | $1.4M |
毛利率NVAXRPD
| Q4 25 | 85.0% | 68.9% | ||
| Q3 25 | 69.5% | 70.2% | ||
| Q2 25 | 93.6% | 70.6% | ||
| Q1 25 | 97.9% | 71.7% | ||
| Q4 24 | 58.5% | 69.5% | ||
| Q3 24 | 28.3% | 70.6% | ||
| Q2 24 | 88.9% | 70.7% | ||
| Q1 24 | 36.9% | 70.3% |
营业利润率NVAXRPD
| Q4 25 | 9.7% | 1.0% | ||
| Q3 25 | -252.7% | 2.7% | ||
| Q2 25 | 42.2% | 1.6% | ||
| Q1 25 | 77.4% | -0.0% | ||
| Q4 24 | — | 3.4% | ||
| Q3 24 | -158.6% | 6.0% | ||
| Q2 24 | 38.7% | 2.5% | ||
| Q1 24 | -154.3% | 4.7% |
净利率NVAXRPD
| Q4 25 | 11.9% | 1.4% | ||
| Q3 25 | -287.3% | 4.5% | ||
| Q2 25 | 44.5% | 3.9% | ||
| Q1 25 | 77.8% | 1.0% | ||
| Q4 24 | — | 1.0% | ||
| Q3 24 | -143.5% | 7.2% | ||
| Q2 24 | 39.1% | 3.1% | ||
| Q1 24 | -157.2% | 0.7% |
每股收益（稀释后）NVAXRPD
| Q4 25 | $0.28 | $0.05 | ||
| Q3 25 | $-1.25 | $0.15 | ||
| Q2 25 | $0.62 | $0.13 | ||
| Q1 25 | $2.93 | $0.03 | ||
| Q4 24 | — | $0.08 | ||
| Q3 24 | $-0.76 | $0.21 | ||
| Q2 24 | $0.99 | $0.09 | ||
| Q1 24 | $-1.05 | $0.02 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $735.1M | $474.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $-127.8M | $154.7M |
| 总资产 | $1.2B | $1.7B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资NVAXRPD
| Q4 25 | $735.1M | $474.7M | ||
| Q3 25 | $762.9M | $407.1M | ||
| Q2 25 | $612.3M | $511.7M | ||
| Q1 25 | $731.5M | $493.5M | ||
| Q4 24 | $923.1M | $521.7M | ||
| Q3 24 | $909.5M | $443.7M | ||
| Q2 24 | $1.0B | $442.6M | ||
| Q1 24 | $480.6M | $411.7M |
股东权益NVAXRPD
| Q4 25 | $-127.8M | $154.7M | ||
| Q3 25 | $-156.7M | $127.2M | ||
| Q2 25 | $37.6M | $90.4M | ||
| Q1 25 | $-75.6M | $52.7M | ||
| Q4 24 | $-623.8M | $17.7M | ||
| Q3 24 | $-526.4M | $-5.1M | ||
| Q2 24 | $-431.7M | $-52.6M | ||
| Q1 24 | $-867.1M | $-86.4M |
总资产NVAXRPD
| Q4 25 | $1.2B | $1.7B | ||
| Q3 25 | $1.2B | $1.7B | ||
| Q2 25 | $1.3B | $1.6B | ||
| Q1 25 | $1.3B | $1.6B | ||
| Q4 24 | $1.6B | $1.7B | ||
| Q3 24 | $1.7B | $1.6B | ||
| Q2 24 | $1.8B | $1.5B | ||
| Q1 24 | $1.4B | $1.5B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-39.5M | $37.6M |
| 自由现金流经营现金流 - 资本支出 | $-41.6M | $36.4M |
| 自由现金流率自由现金流/营收 | -28.2% | 16.8% |
| 资本支出强度资本支出/营收 | 1.4% | 0.5% |
| 现金转化率经营现金流/净利润 | -2.25× | 12.01× |
| 过去12个月自由现金流最近4个季度 | $-250.2M | $146.2M |
8季度趋势，按日历期对齐
经营现金流NVAXRPD
| Q4 25 | $-39.5M | $37.6M | ||
| Q3 25 | $107.8M | $39.0M | ||
| Q2 25 | $-127.5M | $47.5M | ||
| Q1 25 | $-185.5M | $29.8M | ||
| Q4 24 | $-87.3M | $63.8M | ||
| Q3 24 | $-144.8M | $44.0M | ||
| Q2 24 | $314.3M | $32.9M | ||
| Q1 24 | $-83.6M | $31.1M |
自由现金流NVAXRPD
| Q4 25 | $-41.6M | $36.4M | ||
| Q3 25 | $105.8M | $34.8M | ||
| Q2 25 | $-127.7M | $46.6M | ||
| Q1 25 | $-186.7M | $28.4M | ||
| Q4 24 | $-100.3M | $62.6M | ||
| Q3 24 | $-146.2M | $42.6M | ||
| Q2 24 | $311.4M | $32.6M | ||
| Q1 24 | $-90.4M | $30.4M |
自由现金流率NVAXRPD
| Q4 25 | -28.2% | 16.8% | ||
| Q3 25 | 150.2% | 16.0% | ||
| Q2 25 | -53.4% | 21.8% | ||
| Q1 25 | -28.0% | 13.5% | ||
| Q4 24 | -113.6% | 28.9% | ||
| Q3 24 | -173.0% | 19.9% | ||
| Q2 24 | 74.9% | 15.7% | ||
| Q1 24 | -96.4% | 14.8% |
资本支出强度NVAXRPD
| Q4 25 | 1.4% | 0.5% | ||
| Q3 25 | 2.9% | 1.9% | ||
| Q2 25 | 0.1% | 0.4% | ||
| Q1 25 | 0.2% | 0.6% | ||
| Q4 24 | 14.8% | 0.5% | ||
| Q3 24 | 1.6% | 0.6% | ||
| Q2 24 | 0.7% | 0.1% | ||
| Q1 24 | 7.3% | 0.3% |
现金转化率NVAXRPD
| Q4 25 | -2.25× | 12.01× | ||
| Q3 25 | — | 3.97× | ||
| Q2 25 | -1.20× | 5.70× | ||
| Q1 25 | -0.36× | 14.14× | ||
| Q4 24 | — | 29.36× | ||
| Q3 24 | — | 2.85× | ||
| Q2 24 | 1.94× | 5.03× | ||
| Q1 24 | — | 22.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NVAX
| Licensing Royalties And Other | $107.9M | 73% |
| Products | $39.2M | 27% |
RPD
| Products | $209.1M | 96% |
| Services | $8.2M | 4% |
